Ryan J J, Ahmed A, Kind P D, Thompson C B, Berning A K, Sell K W
J Immunol. 1984 Aug;133(2):606-15.
Specific mixed lymphocyte reaction (MLR) responsiveness to allogeneic major histocompatibility complex (MHC), or minor lymphocyte-stimulating (Mls) determinants, was depleted in the peripheral blood lymphocytes (PBL) obtained from mice 24 to 48 hr after i.v. injection of 5 to 7.5 X 10(7) MHC or Mlsa-incompatible spleen cells, respectively. Results of cell mixture experiments suggest that the generation of suppressor cells was not the explanation for this specific reduction in MLR proliferation occurring with these PBL responder cells. To gain additional insight into parameters involved in the recognition of allodeterminants in vivo, experimental manipulations of the host environment and donor cell inoculum utilized in the negative selection procedure were employed. For example, removal of the spleen in the recipient animal, an anatomic site in which injected allogeneic cells and corresponding host antigen-reactive cells (ARC) are trapped, still permitted the specific depletion in murine PBL of host ARC for donor foreign MHC antigens. This finding may implicate other sites such as the liver where unprimed host alloreactive clones are trapped. In addition, irradiation of allogeneic donor cells significantly reduced their capacity to trap alloreactive T cell clones in vivo, whereas heat treatment of the donor cells completely eliminated this ability, even though the Ia determinants were still expressed, measured by flow cytometry. After the negative selection period, kinetic analysis of proliferation showed that 3, 4, or 5 days after injection of MHC-incompatible allogeneic spleen cells, the PBL of the recipient showed specific hyperresponsiveness to the MHC-haplotype of the donor cells. Interestingly, these primed PBL responder cells had the volume distribution of small resting cells; thoracic duct lymphocytes (TDL), positively selected by adoptive transfer of T cells to irradiated semiallogeneic recipients, are reported to be mainly blast cells. In contrast to the MLR hyperresponsiveness that results from priming with MHC-incompatible splenocytes, PBL, obtained at these later time points from mice primed with Mlsa-incompatible, H-2-compatible splenocytes, showed complete unresponsiveness in MLR to these Mlsa-bearing stimulator cells, as well as some nonspecific reduction in proliferation to MHC-incompatible stimulator cells regardless of their Mls genotype.(ABSTRACT TRUNCATED AT 400 WORDS)
静脉注射5至7.5×10⁷个分别与主要组织相容性复合体(MHC)或次要淋巴细胞刺激(Mls)决定簇不相容的脾细胞后24至48小时,从小鼠获得的外周血淋巴细胞(PBL)中,对同种异体MHC或Mls决定簇的特异性混合淋巴细胞反应(MLR)反应性降低。细胞混合实验结果表明,抑制细胞的产生并不能解释这些PBL反应细胞发生的MLR增殖的这种特异性降低。为了进一步深入了解体内同种异体决定簇识别所涉及的参数,我们采用了在阴性选择程序中对宿主环境和供体细胞接种物进行实验操作的方法。例如,去除受体动物的脾脏,这是一个注射的同种异体细胞和相应宿主抗原反应性细胞(ARC)会被困住的解剖部位,但仍然能够使小鼠PBL中针对供体外来MHC抗原的宿主ARC特异性耗竭。这一发现可能暗示了其他部位,如肝脏,未致敏的宿主同种异体反应性克隆会被困在那里。此外,照射同种异体供体细胞显著降低了它们在体内捕获同种异体反应性T细胞克隆的能力,而对供体细胞进行热处理则完全消除了这种能力,尽管通过流式细胞术检测发现Ia决定簇仍有表达。在阴性选择期后,增殖的动力学分析表明,注射与MHC不相容的同种异体脾细胞后3、4或5天,受体的PBL对供体细胞的MHC单倍型表现出特异性高反应性。有趣的是,这些致敏的PBL反应细胞具有小静止细胞的体积分布;据报道,通过将T细胞过继转移到经照射的半同种异体受体中而阳性选择的胸导管淋巴细胞(TDL)主要是母细胞。与用与MHC不相容的脾细胞致敏导致的MLR高反应性相反,在这些较晚时间点从小鼠获得的用与Mlsa不相容、H-2相容的脾细胞致敏的PBL,在MLR中对这些携带Mlsa的刺激细胞表现出完全无反应性,并且对与MHC不相容的刺激细胞的增殖也有一些非特异性降低,无论它们的Mls基因型如何。(摘要截断于400字)